BioImpacts
eISSN: 2228-5660pISSN: 2228-5652
Open AccessShare this on:
Key Metrics
CiteScore 
6
Eigenfactor
0.001 - 0.005
Impact Factor
< 5
SJR
Q1Pharmaceutical Science
Topics Covered
Platelet-rich plasma
Colorectal cancer
Shikimate kinase
Antibacterial activity
Genotype
Cinnamon Oil
Starch
Hematopoietic stem cell transplantation
Peptide vaccine
Curcuma amada
Drug delivery
Blood flow
Causative
Tumor microenvironment
Marrow transplantation
Probiotic
Krabbe disease
Breast cancer
Lactobacillus plantarum
Journal Specifications
Indexed in the following public directories
Scopus 
DOAJ 
Web of Science
Overview
- PublisherTabriz University of Medical Sciences
- LanguageEnglish
- FrequencyQuarterly
- Publication Time5
- Editorial Review ProcessPeer review
General Details
- LanguageEnglish
- FrequencyQuarterly
- Publication Start Year2011
- Publisher URL
- Website URL
Publication Details
- Plagiarism
- Publication Time5
Editorial Review Detail
- Editorial Team
- Review ProcessPeer review
- Review Url
- Author instructions
- Copyright Details
- License typeCC BY-NC
- OA statement
View less
Planning to publish in BioImpacts ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers
Optogenetics: A new tool for cancer investigation and treatment.
- 1 Jan 2022
- BioImpacts : BI
Advance trends in targeting homology-directed repair for accurate gene editing: An inclusive review of small molecules and modified CRISPR-Cas9 systems.
- 1 Jan 2022
- BioImpacts : BI
TEM1-targeting PEGylated PLGA shikonin nanoformulation for immunomodulation and eradication of ovarian cancer.
- 1 Jan 2022
- BioImpacts : BI
Molecular docking, molecular dynamics simulation, and ADMET analysis of levamisole derivatives against the SARS-CoV-2 main protease (MPro).
- 1 Jan 2022
- BioImpacts : BI
High efficacy of tamoxifen-loaded L-lysine coated magnetic iron oxide nanoparticles in cell cycle arrest and anti-cancer activity for breast cancer therapy.
- 1 Jan 2022
- BioImpacts : BI
Recent advancements in cell-based models for auditory disorders.
- 1 Jan 2022
- BioImpacts : BI
Optogenetics: A new tool for cancer investigation and treatment.
- 1 Jan 2022
- BioImpacts : BI
Advance trends in targeting homology-directed repair for accurate gene editing: An inclusive review of small molecules and modified CRISPR-Cas9 systems.
- 1 Jan 2022
- BioImpacts : BI
TEM1-targeting PEGylated PLGA shikonin nanoformulation for immunomodulation and eradication of ovarian cancer.
- 1 Jan 2022
- BioImpacts : BI
Molecular docking, molecular dynamics simulation, and ADMET analysis of levamisole derivatives against the SARS-CoV-2 main protease (MPro).
- 1 Jan 2022
- BioImpacts : BI
High efficacy of tamoxifen-loaded L-lysine coated magnetic iron oxide nanoparticles in cell cycle arrest and anti-cancer activity for breast cancer therapy.
- 1 Jan 2022
- BioImpacts : BI
Recent advancements in cell-based models for auditory disorders.
- 1 Jan 2022
- BioImpacts : BI
FAQs
How long has BioImpacts been actively publishing? 
BioImpacts has been in operation since 2011 till date.
What is the publishing frequency of BioImpacts?
BioImpacts published with a Quarterly frequency.
How many articles did BioImpacts publish last year?
In 2022, BioImpacts publsihed 22 articles.
What is the eISSN & pISSN for BioImpacts?
For BioImpacts, eISSN is 2228-5660 and pISSN is 2228-5652.
What is Citescore for BioImpacts?
Citescore for BioImpacts is 6.
What is the SJR for BioImpacts?
SJR for BioImpacts is Q1.
Who is the publisher of BioImpacts?
Tabriz University of Medical Sciences is the publisher of BioImpacts.